Alpha-to-beta Cell Trans-differentiation for Treatment of Diabetes

Overview

Journal Biochem Soc Trans

Specialty Biochemistry

Date 2021 Dec 9

PMID 34882233

Citations 7

Authors

Mohamed Saleh

George K Gittes

Krishna Prasadan

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus is a significant cause of morbidity and mortality in the United States and worldwide. According to the CDC, in 2017, ∼34.2 million of the American population had diabetes. Also, in 2017, diabetes was the seventh leading cause of death and has become the number one biomedical financial burden in the United States. Insulin replacement therapy and medications that increase insulin secretion and improve insulin sensitivity are the main therapies used to treat diabetes. Unfortunately, there is currently no radical cure for the different types of diabetes. Loss of β cell mass is the end result that leads to both type 1 and type 2 diabetes. In the past decade, there has been an increased effort to develop therapeutic strategies to replace the lost β cell mass and restore insulin secretion. α cells have recently become an attractive target for replacing the lost β cell mass, which could eventually be a potential strategy to cure diabetes. This review highlights the advantages of using α cells as a source for generating new β cells, the various investigative approaches to convert α cells into insulin-producing cells, and the future prospects and problems of this promising diabetes therapeutic strategy.

Citing Articles

Decoding the Significance of Alpha Cell Function in the Pathophysiology of Type 1 Diabetes.

Carroll J, Chen J, Mittal R, Lemos J, Mittal M, Juneja S Cells. 2024; 13(22).

PMID: 39594662 PMC: 11593172. DOI: 10.3390/cells13221914.

Type 1 diabetes: immune pathology and novel therapeutic approaches.

Ling E, Lemos J, Hirani K, von Herrath M Diabetol Int. 2024; 15(4):761-776.

PMID: 39469552 PMC: 11512973. DOI: 10.1007/s13340-024-00748-z.

Hesperidin activates the GLP-1R/cAMP-CREB/IRS2/PDX1 pathway to promote transdifferentiation of islet α cells into β cells Across the spectrum.

Zhang W, Wu L, Qu R, Liu T, Wang J, Tong Y Heliyon. 2024; 10(16):e35424.

PMID: 39220963 PMC: 11365324. DOI: 10.1016/j.heliyon.2024.e35424.

Sex-based impact of pancreatic islet stressors in GluCreERT2/Rosa26-eYFP mice.

Tanday N, Coulter-Parkhill A, Moffett R, Suruli K, Dubey V, Flatt P J Endocrinol. 2023; 259(2).

PMID: 37650517 PMC: 10563506. DOI: 10.1530/JOE-23-0174.

EpiCRISPR targeted methylation of Arx gene initiates transient switch of mouse pancreatic alpha to insulin-producing cells.

dordevic M, Stepper P, Feuerstein-Akgoz C, Gerhauser C, Paunovic V, Tolic A Front Endocrinol (Lausanne). 2023; 14:1134478.

PMID: 37008919 PMC: 10063207. DOI: 10.3389/fendo.2023.1134478.

References

Zhang Q, Ramracheya R, Lahmann C, Tarasov A, Bengtsson M, Braha O . Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes. Cell Metab. 2013; 18(6):871-82. PMC: 3851686. DOI: 10.1016/j.cmet.2013.10.014. View

Ohlsson H, Karlsson K, Edlund T . IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J. 1993; 12(11):4251-9. PMC: 413720. DOI: 10.1002/j.1460-2075.1993.tb06109.x. View

Hang Y, Stein R . MafA and MafB activity in pancreatic β cells. Trends Endocrinol Metab. 2011; 22(9):364-73. PMC: 3189696. DOI: 10.1016/j.tem.2011.05.003. View

McKimpson W, Accili D . Reprogramming Cells to Make Insulin. J Endocr Soc. 2019; 3(6):1214-1226. PMC: 6546342. DOI: 10.1210/js.2019-00040. View

Godinho R, Mega C, Teixeira-de-Lemos E, Carvalho E, Teixeira F, Fernandes R . The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?. J Diabetes Res. 2015; 2015:806979. PMC: 4449938. DOI: 10.1155/2015/806979. View

Marin-Penalver J, Martin-Timon I, Sevillano-Collantes C, Del Canizo-Gomez F . Update on the treatment of type 2 diabetes mellitus. World J Diabetes. 2016; 7(17):354-95. PMC: 5027002. DOI: 10.4239/wjd.v7.i17.354. View

Michael Rukstalis J, Habener J . Neurogenin3: a master regulator of pancreatic islet differentiation and regeneration. Islets. 2010; 1(3):177-84. DOI: 10.4161/isl.1.3.9877. View

Rall L, Pictet R, Williams R, Rutter W . Early differentiation of glucagon-producing cells in embryonic pancreas: a possible developmental role for glucagon. Proc Natl Acad Sci U S A. 1973; 70(12):3478-82. PMC: 427263. DOI: 10.1073/pnas.70.12.3478. View

Ariyachet C, Tovaglieri A, Xiang G, Lu J, Shah M, Richmond C . Reprogrammed Stomach Tissue as a Renewable Source of Functional β Cells for Blood Glucose Regulation. Cell Stem Cell. 2016; 18(3):410-21. PMC: 4779391. DOI: 10.1016/j.stem.2016.01.003. View

10.

Wei R, Gu L, Yang J, Yang K, Liu J, Le Y . Antagonistic Glucagon Receptor Antibody Promotes α-Cell Proliferation and Increases β-Cell Mass in Diabetic Mice. iScience. 2019; 16:326-339. PMC: 6581654. DOI: 10.1016/j.isci.2019.05.030. View

11.

Pipeleers D, Keymeulen B, Chatenoud L, Hendrieckx C, Ling Z, Mathieu C . A view on beta cell transplantation in diabetes. Ann N Y Acad Sci. 2002; 958:69-76. DOI: 10.1111/j.1749-6632.2002.tb02948.x. View

12.

Conrad E, Dai C, Spaeth J, Guo M, Cyphert H, Scoville D . The MAFB transcription factor impacts islet α-cell function in rodents and represents a unique signature of primate islet β-cells. Am J Physiol Endocrinol Metab. 2015; 310(1):E91-E102. PMC: 4675799. DOI: 10.1152/ajpendo.00285.2015. View

13.

Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I . Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med. 2000; 6(5):568-72. DOI: 10.1038/75050. View

14.

Atkinson M, Eisenbarth G, Michels A . Type 1 diabetes. Lancet. 2013; 383(9911):69-82. PMC: 4380133. DOI: 10.1016/S0140-6736(13)60591-7. View

15.

Thorel F, Nepote V, Avril I, Kohno K, Desgraz R, Chera S . Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature. 2010; 464(7292):1149-54. PMC: 2877635. DOI: 10.1038/nature08894. View

16.

Abdul-Ghani M, Jenkinson C, Richardson D, Tripathy D, DeFronzo R . Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006; 55(5):1430-5. DOI: 10.2337/db05-1200. View

17.

Talchai C, Xuan S, Kitamura T, DePinho R, Accili D . Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat Genet. 2012; 44(4):406-12, S1. PMC: 3315609. DOI: 10.1038/ng.2215. View

18.

Xiao X, Guo P, Shiota C, Zhang T, Coudriet G, Fischbach S . Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes. Cell Stem Cell. 2018; 22(1):78-90.e4. PMC: 5757249. DOI: 10.1016/j.stem.2017.11.020. View

19.

Sapir T, Shternhall K, Meivar-Levy I, Blumenfeld T, Cohen H, Skutelsky E . Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci U S A. 2005; 102(22):7964-9. PMC: 1142350. DOI: 10.1073/pnas.0405277102. View

20.

Weir G, Butler P, Bonner-Weir S . The β-cell glucose toxicity hypothesis: Attractive but difficult to prove. Metabolism. 2021; 124:154870. PMC: 8530963. DOI: 10.1016/j.metabol.2021.154870. View